Episode 174: Breakthrough Stroke: Diagnostic and Therapeutic Dilemmas
Professor David Seiffge explains breakthrough strokes in patients on antithrombotic therapy, differentiating between antiplatelet and oral anticoagulation use. He highlights the importance of thorough investigations to identify stroke causes in AFib patients, as not all are cardioembolic. Current and emerging treatment strategies, including factor 11 inhibitors and LAA closure, are discussed to improve outcomes for high-risk patients.Topics in this course:
